Islay Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-340
Closed -$81.6K 243
2022
Q4
$81.6K Hold
340
0.09% 107
2022
Q3
$62K Hold
340
0.07% 121
2022
Q2
$57K Sell
340
-990
-74% -$213K 0.06% 177
2022
Q1
$333K Sell
1,330
-3
-0.2% -$753 0.28% 61
2021
Q4
$342K Sell
1,333
-112
-8% -$27.4K 0.26% 61
2021
Q3
$351K Buy
1,445
+113
+8% +$27.6K 0.27% 61
2021
Q2
$275K Buy
1,332
+123
+10% +$25.1K 0.22% 65
2021
Q1
$228K Buy
1,209
+899
+290% +$159K 0.19% 69
2020
Q4
$51K Hold
310
0.05% 173
2020
Q3
$39K Hold
310
0.04% 184
2020
Q2
$30K Hold
310
0.03% 188
2020
Q1
$28K Buy
310
+150
+94% +$19.4K 0.04% 173
2019
Q4
$24K Buy
+160
New +$21.5K 0.02% 197

Other funds holding HCA

Islay Capital Management's HCA Position: Q1 2023 in Review

Islay Capital Management sold out of HCA Healthcare (HCA) in Q1 2023, closing a stake of 340 shares — an estimated $81.6K sold.

Islay Capital Management first reported a position in HCA in Q4 2019 and held it in 13 quarters. The position peaked at $351K in Q3 2021. 970 funds tracked by Wall St. Rank hold HCA as of Q1 2023.

  • Islay Capital Management reported no remaining HCA Healthcare position as of Q1 2023 after selling out during the quarter.
  • Islay Capital Management sold 340 HCA Healthcare shares in Q1 2023, an estimated $81.6K.
  • Islay Capital Management first reported a position in HCA Healthcare in Q4 2019 and held it in 13 quarters.
  • Islay Capital Management's HCA Healthcare position peaked at $351K in Q3 2021.
  • 970 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2023.

Based on Islay Capital Management's 13F filing for Q1 2023, filed 10 May 2023.